2025 Deloitte China's Tomorrow's Star in Medicine and HealthThe list was officially released on December 16, 2025, and Super Vision was successfully selected, fully demonstrating the industry's high recognition of its founding team, technological leadership, business model, and future growth potential. This marks that Super Vision has become an outstanding new force driving innovation and development in the pharmaceutical and health industry.

Image source: Deloitte

The Deloitte High Tech High Growth and Rising Stars selection project was founded in Silicon Valley, USA in 1995 and entered China in 2005. This project aims to recognize outstanding enterprises that continuously innovate and grow rapidly, and is regarded as the 'benchmark for global high growth enterprises'. It is held annually in more than 30 countries around the world. As a key project of the Deloitte High Tech High Growth and Tomorrow's Star selection, the 'Deloitte China Healthcare Tomorrow's Star' project selects outstanding enterprises with leading technology and feasible business models, broad growth space in their respective sub sectors, and leading positions in the field from various dimensions such as technological innovation, founding team, market prospects, enterprise valuation, and industry ranking. Many industry leaders have emerged in the 'High tech High growth' and 'Tomorrow Star' lists, such as Tencent, JD, ByteDance, Mindray Medical, SMIC International, WuXi AppTec, Apple, Microsoft, Tesla, etc.

Image source: Award ceremony venue